Annual EBITDA
-$22.83 M
+$13.73 M+37.55%
December 31, 2023
Summary
- As of February 7, 2025, NPCE annual EBITDA is -$22.83 million, with the most recent change of +$13.73 million (+37.55%) on December 31, 2023.
- During the last 3 years, NPCE annual EBITDA has fallen by -$10.35 million (-82.96%).
- NPCE annual EBITDA is now -82.96% below its all-time high of -$12.48 million, reached on December 31, 2020.
Performance
NPCE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.82 M
+$2.08 M+42.52%
September 30, 2024
Summary
- As of February 7, 2025, NPCE quarterly EBITDA is -$2.82 million, with the most recent change of +$2.08 million (+42.52%) on September 30, 2024.
- Over the past year, NPCE quarterly EBITDA has increased by +$1.85 million (+39.61%).
- NPCE quarterly EBITDA is now -124.26% below its all-time high of -$1.26 million, reached on September 30, 2020.
Performance
NPCE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$17.52 M
+$1.85 M+9.55%
September 30, 2024
Summary
- As of February 7, 2025, NPCE TTM EBITDA is -$17.52 million, with the most recent change of +$1.85 million (+9.55%) on September 30, 2024.
- Over the past year, NPCE TTM EBITDA has increased by +$10.21 million (+36.82%).
- NPCE TTM EBITDA is now -378.61% below its all-time high of -$3.66 million, reached on March 31, 2020.
Performance
NPCE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NPCE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.5% | +39.6% | +36.8% |
| 3 y3 years | -83.0% | +39.6% | +36.8% |
| 5 y5 years | -13.8% | +39.6% | +36.8% |
NPCE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +37.5% | at high | +72.1% | at high | +52.5% |
| 5 y | 5-year | -83.0% | +37.5% | -124.3% | +72.1% | -378.6% | +52.5% |
| alltime | all time | -83.0% | +37.5% | -124.3% | +72.1% | -378.6% | +52.5% |
NeuroPace EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.82 M(-42.5%) | -$17.52 M(-9.5%) |
| Jun 2024 | - | -$4.90 M(-21.5%) | -$19.37 M(-8.0%) |
| Mar 2024 | - | -$6.24 M(+75.6%) | -$21.06 M(-7.8%) |
| Dec 2023 | -$22.83 M(-37.6%) | -$3.56 M(-23.8%) | -$22.83 M(-17.7%) |
| Sep 2023 | - | -$4.67 M(-29.2%) | -$27.73 M(-13.9%) |
| Jun 2023 | - | -$6.60 M(-17.7%) | -$32.20 M(-9.8%) |
| Mar 2023 | - | -$8.02 M(-5.2%) | -$35.70 M(-2.4%) |
| Dec 2022 | -$36.57 M | -$8.45 M(-7.5%) | -$36.57 M(-0.8%) |
| Sep 2022 | - | -$9.14 M(-9.5%) | -$36.87 M(+8.7%) |
| Jun 2022 | - | -$10.09 M(+13.7%) | -$33.91 M(+11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$8.88 M(+1.5%) | -$30.37 M(+7.0%) |
| Dec 2021 | -$28.37 M(+127.4%) | -$8.75 M(+41.6%) | -$28.37 M(+27.3%) |
| Sep 2021 | - | -$6.18 M(-5.7%) | -$22.29 M(+28.4%) |
| Jun 2021 | - | -$6.55 M(-4.8%) | -$17.36 M(+10.5%) |
| Mar 2021 | - | -$6.89 M(+158.5%) | -$15.71 M(+25.8%) |
| Dec 2020 | -$12.48 M(-37.8%) | -$2.66 M(+111.9%) | -$12.48 M(+27.1%) |
| Sep 2020 | - | -$1.26 M(-74.3%) | -$9.82 M(+14.7%) |
| Jun 2020 | - | -$4.90 M(+33.8%) | -$8.56 M(+133.8%) |
| Mar 2020 | - | -$3.66 M | -$3.66 M |
| Dec 2019 | -$20.07 M | - | - |
FAQ
- What is NeuroPace annual EBITDA?
- What is the all time high annual EBITDA for NeuroPace?
- What is NeuroPace annual EBITDA year-on-year change?
- What is NeuroPace quarterly EBITDA?
- What is the all time high quarterly EBITDA for NeuroPace?
- What is NeuroPace quarterly EBITDA year-on-year change?
- What is NeuroPace TTM EBITDA?
- What is the all time high TTM EBITDA for NeuroPace?
- What is NeuroPace TTM EBITDA year-on-year change?
What is NeuroPace annual EBITDA?
The current annual EBITDA of NPCE is -$22.83 M
What is the all time high annual EBITDA for NeuroPace?
NeuroPace all-time high annual EBITDA is -$12.48 M
What is NeuroPace annual EBITDA year-on-year change?
Over the past year, NPCE annual EBITDA has changed by +$13.73 M (+37.55%)
What is NeuroPace quarterly EBITDA?
The current quarterly EBITDA of NPCE is -$2.82 M
What is the all time high quarterly EBITDA for NeuroPace?
NeuroPace all-time high quarterly EBITDA is -$1.26 M
What is NeuroPace quarterly EBITDA year-on-year change?
Over the past year, NPCE quarterly EBITDA has changed by +$1.85 M (+39.61%)
What is NeuroPace TTM EBITDA?
The current TTM EBITDA of NPCE is -$17.52 M
What is the all time high TTM EBITDA for NeuroPace?
NeuroPace all-time high TTM EBITDA is -$3.66 M
What is NeuroPace TTM EBITDA year-on-year change?
Over the past year, NPCE TTM EBITDA has changed by +$10.21 M (+36.82%)